Zobrazeno 1 - 10
of 395
pro vyhledávání: '"Papaldo P"'
Autor:
Fabi A, Giannarelli D, Malaguti P, Ferretti G, Vari S, Papaldo P, Nisticò C, Caterino M, De Vita R, Mottolese M, Iacorossi L, Cognetti F
Publikováno v:
Drug Design, Development and Therapy, Vol 2015, Iss default, Pp 6177-6183 (2015)
Alessandra Fabi,1 Diana Giannarelli,2 Paola Malaguti,1 Gianluigi Ferretti,1 Sabrina Vari,1 Paola Papaldo,1 Cecilia Nisticò,1 Mauro Caterino,3 Roy De Vita,4 Marcella Mottolese,5 Laura Iacorossi,6 Francesco Cognetti1 1Department of Medical Oncology, 2
Externí odkaz:
https://doaj.org/article/a67be69b2637414a9144063f909f9311
Autor:
Fabi Alessandra, Russillo Michelangelo, Ferretti Gianluigi, Metro Giulio, Nisticò Cecilia, Papaldo Paola, De Vita Ferdinando, D’Auria Giuliana, Vidiri Antonello, Giannarelli Diana, Cognetti Francesco
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 482 (2012)
Abstract Background Data on efficacy of bevacizumab (B) beyond first-line taxane -including regimen (BT) as first-line treatment are lacking. Although preclinical results that anti-angiogenic agents combined with hormonal therapy (HT) could be active
Externí odkaz:
https://doaj.org/article/7c90707cb1a14714928c369ae027b750
Autor:
Russillo Michelangelo, Nisticò Cecilia, Milella Michele, Carlini Paolo, Sperduti Isabella, Fabi Alessandra, Puglisi Fabio, Vaccaro Vanja, Bria Emilio, Cuppone Federica, Papaldo Paola, Ferretti Gianluigi, Aapro Matti, Giannarelli Diana, Cognetti Francesco
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 30, Iss 1, p 54 (2011)
Abstract Background Although the addition of bevacizumab significantly improves the efficacy of chemotherapy for advanced breast cancer, regulatory concerns still exist with regard to the magnitude of the benefits and the overall safety profile. Meth
Externí odkaz:
https://doaj.org/article/e1419c745aa2417783f0f2a91095f707
Autor:
Metro, G., Foglietta, J., Russillo, M., Stocchi, L., Vidiri, A., Giannarelli, D., Crinò, L., Papaldo, P., Mottolese, M., Cognetti, F., Fabi, A., Gori, S. *
Publikováno v:
In Annals of Oncology March 2011 22(3):625-630
Autor:
Papaldo, P., Fabi, A., Ferretti, G. *, Mottolese, M., Cianciulli, A.M., Di Cocco, B., Pino, M.S., Carlini, P., Di Cosimo, S., Sacchi, I., Sperduti, I., Nardoni, C., Cognetti, F.
Publikováno v:
In Annals of Oncology April 2006 17(4):630-636
Autor:
Di Costanzo, F. *, Gasperoni, S., Papaldo, P., Bilancia, D., Manzione, L., Landucci, E., Mazzoni, F., Cognetti, F.
Publikováno v:
In Annals of Oncology January 2006 17(1):79-84
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Di Cosimo, S., Alimonti, A., Ferretti, G. *, Sperduti, I., Carlini, P., Papaldo, P., Fabi, A., Gelibter, A., Ciccarese, M., Giannarelli, D., Mandalà, M., Milella, M., Ruggeri, E.M., Cognetti, F.
Publikováno v:
In Annals of Oncology July 2004 15(7):1065-1071
Autor:
Carlini, P. *, Frassoldati, A., De Marco, S., Casali, A., Ruggeri, E.M., Nardi, M., Papaldo, P., Fabi, A., Paoloni, F., Cognetti, F.
Publikováno v:
In Annals of Oncology November 2001 12(11):1539-1543
Autor:
Venturini, M. *, Michelotti, A., Papaldo, P., Del Mastro, L., Bergaglio, M., Lionetto, R., Lunardi, G., Sguotti, C., Frevola, L., Donati, S., Rosso, R., Cognetti, F.
Publikováno v:
In Annals of Oncology August 2001 12(8):1097-1106